Glenmark to Conduct Trials in India for Potential CO...
Glenmark Pharmaceuticals Ltd. said on Thursday it will start clinical trials in India of antiviral drug favipiravir, seen as a potential treatment for COVID-19, sending its shares up as much as 9%. The trials ...
April 30, 2020
1:02 pm By Neha Mule